Current Report · Items 1.01, 2.03, 3.02, 9.01 · 8-K
GlucoTrack, Inc.
Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement · Unregistered Sales of Equity Securities
Item 3.02. Unregistered Sales of Equity Securities To the extent required by Item 3.02 of Form 8-K, the information contained in Item 1.01 is hereby incorporated by reference into this Item 3.02 in its entirety.
Filed Jul 27, 2026Accepted Jul 27, 2026, 4:30 PM EDTCIK 1506983Accession 0001493152-26-034815
Company context
Inc. Glucotrack, Inc. (NASDAQ: GCTK) is focused on the design, development, and commercialization of novel technologies for people with diabetes. The Company is currently developing a long-term implantable continuous blood glucose monitoring system for people living with diabetes. Glucotrack’s CBGM is a long-term, implantable system that continually measures blood glucose levels with a sensor longevity of 3 years, no on-body wearable component and with minimal calibration. For more information, please visit http://www.glucotrack.com.
Current securities
Historical securities (2)
Registered securities in this filing
GLUCOTRACK, INC. · 8-K · Filed 2026-07-27
As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.
Common Stock
- Symbol
- GCTK
- Exchange
- NASDAQ
- Classification
- COMMON
Filing context
Context: AsOf2026-07-22
Dimensions: Not supplied
Accession 000149315226034815 · 1 registered-security cover member
Read the exact SEC filing ↗Disclosure sections
Items 1.01, 2.03, 3.02, 9.01Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 3.02Item 3.02 - Unregistered Sales of Equity
Item
3.02. Unregistered Sales of Equity Securities
To
the extent required by Item 3.02 of Form 8-K, the information contained in Item 1.01 is hereby incorporated by reference into this Item
3.02 in its entirety.